Latest News for: bcma

Edit

Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for ...

Montana Standard 27 Jan 2026
SAN FRANCISCO and SUZHOU, China, Jan ... ("Innovent") (HKEX.
Edit

Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma

PR Newswire 27 Jan 2026
In this cohort, the ORR was 80% among 10 patients with extramedullary disease (EMD) and 77.8% among 9 patients previously treated with BCMA- and/or GPRC5D-directed therapies ... About IBI3003 (Anti-GPRC5D/BCMA/CD3 Trispecific Antibody).
Edit

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

The Berkshire Eagle 29 Dec 2025
SHANGHAI, Dec.
  • 1

Article Search

tools
×
×
×
×